Fate Therapeutics to Present at Upcoming December Investor Conferences
Fate Therapeutics (NASDAQ: FATE), a clinical-stage biopharmaceutical company focused on iPSC-derived cellular immunotherapies for cancer and autoimmune diseases, has announced its participation in two major healthcare conferences this December. The company will join Citi's 2024 Global Healthcare Conference in Miami on December 3, featuring a panel discussion at 2:30 PM ET, and Piper Sandler's 36th Annual Healthcare Conference in New York on December 4, participating in both a panel discussion at 3:00 PM ET and a fireside chat at 4:00 PM ET. Live webcasts will be available on the company's website under Events & Presentations.
Fate Therapeutics (NASDAQ: FATE), una società biofarmaceutica in fase clinica focalizzata su immunoterapie cellulari derivate da iPSC per il cancro e le malattie autoimmuni, ha annunciato la sua partecipazione a due importanti conferenze sanitarie questo dicembre. La compagnia parteciperà alla 2024 Global Healthcare Conference di Citi a Miami il 3 dicembre, con una discussione di pannello alle 14:30 ET, e alla 36ª Annual Healthcare Conference di Piper Sandler a New York il 4 dicembre, partecipando sia a una discussione di pannello alle 15:00 ET che a un colloquio informale alle 16:00 ET. Le dirette streaming saranno disponibili sul sito web della compagnia nella sezione Eventi & Presentazioni.
Fate Therapeutics (NASDAQ: FATE), una empresa biofarmacéutica en etapa clínica centrada en inmunoterapias celulares derivadas de iPSC para el cáncer y enfermedades autoinmunes, ha anunciado su participación en dos importantes conferencias de salud este diciembre. La compañía se unirá a la 2024 Global Healthcare Conference de Citi en Miami el 3 de diciembre, con un panel de discusión a las 14:30 ET, y a la 36ª Annual Healthcare Conference de Piper Sandler en Nueva York el 4 de diciembre, participando en un panel de discusión a las 15:00 ET y en un chat informal a las 16:00 ET. Las transmisiones en vivo estarán disponibles en el sitio web de la compañía bajo Eventos y Presentaciones.
Fate Therapeutics (NASDAQ: FATE)는 암 및 자가면역질환을 위한 iPSC 유래 세포 면역 요법에 집중하는 임상 단계 생명공학 회사로, 이번 12월 두 개의 주요 의료 컨퍼런스에 참가한다고 발표했습니다. 이 회사는 12월 3일 마이애미에서 열리는 Citi의 2024 Global Healthcare Conference에 참여하여 오후 2시 30분 ET에 패널 토론을 진행하며, 12월 4일 뉴욕에서 열리는 Piper Sandler의 36번째 연례 의료 컨퍼런스에서는 오후 3시 ET에 패널 토론과 오후 4시 ET에 파이어사이드 챗에 참여할 예정입니다. 생중계는 회사 웹사이트의 이벤트 및 프레젠테이션 섹션에서 확인하실 수 있습니다.
Fate Therapeutics (NASDAQ: FATE), une entreprise biopharmaceutique en phase clinique axée sur les immunothérapies cellulaires dérivées des iPSC pour le cancer et les maladies auto-immunes, a annoncé sa participation à deux grandes conférences dans le domaine de la santé ce mois de décembre. L'entreprise participera à la 2024 Global Healthcare Conference de Citi à Miami le 3 décembre, avec une discussion en panel à 14h30 ET, et à la 36ème Annual Healthcare Conference de Piper Sandler à New York le 4 décembre, participant à la fois à une discussion en panel à 15h00 ET et à un entretien informel à 16h00 ET. Des diffusions en direct seront disponibles sur le site Web de l'entreprise dans la section Événements & Présentations.
Fate Therapeutics (NASDAQ: FATE), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf iPSC-abgeleitete Zellimmuntherapien für Krebs und Autoimmunerkrankungen spezialisiert hat, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im Dezember bekannt gegeben. Das Unternehmen wird am 3. Dezember an der 2024 Global Healthcare Conference von Citi in Miami teilnehmen, die eine Podiumsdiskussion um 14:30 Uhr ET umfasst, sowie an der 36. Annual Healthcare Conference von Piper Sandler in New York am 4. Dezember, wo es sowohl an einer Podiumsdiskussion um 15:00 Uhr ET als auch an einem informellen Gespräch um 16:00 Uhr ET teilnehmen wird. Live-Webcasts werden auf der Unternehmenswebsite unter Veranstaltungen & Präsentationen verfügbar sein.
- None.
- None.
SAN DIEGO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will participate in the following upcoming investor conferences:
- Citi’s 2024 Global Healthcare Conference, including a panel discussion at 2:30 PM ET on Tuesday, December 3, 2024 in Miami, Florida; and
- Piper Sandler’s 36th Annual Healthcare Conference, including a panel discussion at 3:00 PM ET and a fireside chat at 4:00 PM ET on Wednesday, December 4, 2024 in New York, New York.
A live webcast, if recorded, of each presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website shortly after the event.
About Fate Therapeutics, Inc.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s pipeline includes iPSC-derived natural killer (NK) cell and T-cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.
Contact:
Christina Tartaglia
Precision AQ
212.362.1200
christina.tartaglia@precisionaq.com
FAQ
What investor conferences will Fate Therapeutics (FATE) attend in December 2024?
What time is Fate Therapeutics' (FATE) presentation at Citi's Healthcare Conference?
Where can investors watch Fate Therapeutics' (FATE) conference presentations?
What are Fate Therapeutics' (FATE) scheduled times for the Piper Sandler Healthcare Conference?
